4
Changes in Ownership
INOVIO PHARMACEUTICALS, INC. Filed Acc 0001771498-26-000005
Chief Executive Officer gave up 12,306 shares (to pay taxes)
- Chief Executive Officer acquired 28,296 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Shea Jacqueline Elizabeth · Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-05-20 | Exercise or conversion : show line 1 in the form | +28,296 | 123,327 | D | ||
| 2026-05-20 | Shares withheld for taxes : show line 2 in the form | −12,306 | $1.23 | $15,136 | 111,021 | D |
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-05-20 | Exercise or conversion : show line 3 in the form Restricted Stock Unit | −28,296 | 56,592 | D |
| 2026-05-20 | Grant or award : show line 4 in the form Common Stock Option | +123,760 | 123,760 | D |
| 2026-05-20 | Grant or award : show line 5 in the form Restricted Stock Unit | +100,240 | 100,240 | D |
Loading xslF345X06/wk-form4_1779393839.xml…